Dashboard
Curated content
All companies
Job board
Funding rounds
Exits
Matching tool
Investment heatmap
Companies
Arxx Therapeutics
Team
Team
Save
Arxx Therapeutics
Develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis.
Launch date
2019
Employees
2-10 people
Company register number
815295242
Oslo Norway (HQ)
View more
https://arxxtx.com/
https://www.linkedin.com/company/arxx-therapeutics/
B2B
manufacturing
commission
health
biotechnology
hard tech
biotechnology
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Patents (2)
Authorizing premium user...